Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 22, 2020 Off

Liva Healthcare Supports National Weight Loss Service With LloydsPharmacy

By BusinessWire

LONDON–(BUSINESS WIRE)–Liva Healthcare is providing vital lifestyle and weight loss support in collaboration with LloydsPharmacy to help tackle the UK’s…

July 22, 2020 Off

Liva Healthcare Supports National Weight Loss Service With LloydsPharmacy

By BusinessWire

LONDON–(BUSINESS WIRE)–Liva Healthcare is providing vital lifestyle and weight loss support in collaboration with LloydsPharmacy to help tackle the UK’s…

July 22, 2020 Off

Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures

By BusinessWire

Investment addresses today’s challenge to efficiently transport next-generation therapeutics such as cell and gene therapy to the target and unlock…

July 22, 2020 Off

Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures

By BusinessWire

Investment addresses today’s challenge to efficiently transport next-generation therapeutics such as cell and gene therapy to the target and unlock…

July 22, 2020 Off

A Versatile Vessel for Next-gen Therapeutics: Harvard’s ARMMs Technology to Be Commercialized by Vesigen Therapeutics

By BusinessWire

  CAMBRIDGE, Mass.–(BUSINESS WIRE)–Harvard University’s Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today…

July 22, 2020 Off

A Versatile Vessel for Next-gen Therapeutics: Harvard’s ARMMs Technology to Be Commercialized by Vesigen Therapeutics

By BusinessWire

  CAMBRIDGE, Mass.–(BUSINESS WIRE)–Harvard University’s Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today…

July 22, 2020 Off

ERC-USA Announces Expansion of Glioblastoma Right-to-Try Treatment for ERC1671 with NYU Winthrop Hospital

By BusinessWire

PASADENA, Calif.–(BUSINESS WIRE)–ERC-USA, a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer, today announced that NYU Winthrop Hospital…

July 22, 2020 Off

ERC-USA Announces Expansion of Glioblastoma Right-to-Try Treatment for ERC1671 with NYU Winthrop Hospital

By BusinessWire

PASADENA, Calif.–(BUSINESS WIRE)–ERC-USA, a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer, today announced that NYU Winthrop Hospital…

July 22, 2020 Off

IQVIA Reports Second-Quarter 2020 Results and Raises Full-Year 2020 Guidance

By BusinessWire

Second quarter revenue $2,521 million and Adjusted EBITDA $483 million GAAP Diluted Earnings per Share $(0.12); Adjusted Diluted Earnings per…

July 22, 2020 Off

IQVIA Reports Second-Quarter 2020 Results and Raises Full-Year 2020 Guidance

By BusinessWire

Second quarter revenue $2,521 million and Adjusted EBITDA $483 million GAAP Diluted Earnings per Share $(0.12); Adjusted Diluted Earnings per…

Posts pagination

Previous 1 … 4,718 4,719 4,720 … 6,211 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Constipation Treatment Market to Grow by $8 Billion During 2025-2030 Driven by Increasing Demand for OTC Laxatives and Natural Remedies – ResearchAndMarkets.com

December 17, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine